Meloxicam Kleva 15 Mg

Meloxicam, the active ingredient in Meloxicam Kleva 15 mg, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a 15 mg oral tablet for oral use. It treats pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute pain in adults.

GNH USA supplies Meloxicam Kleva 15 mg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company provides reliable sourcing, regulatory support and global logistics to meet the needs of healthcare providers, ensuring timely delivery across multiple continents while adhering to stringent quality standards.

Meloxicam is an NSAID used to manage inflammatory musculoskeletal conditions.

Osteoarthritis: reduces joint pain and swelling, improving mobility. Rheumatoid arthritis: alleviates chronic inflammation and slows joint damage progression. Ankylosing spondylitis: improves spinal pain and stiffness, enhancing function. Acute pain: provides short‑term relief of moderate to severe pain.

Meloxicam may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal discomfort (e.g., dyspepsia, nausea) - Headache - Dizziness - Mild skin rash

Serious or Rare Side Effects: - Gastrointestinal ulcer or bleeding - Severe liver injury (hepatitis, jaundice) - Anaphylactic or severe allergic reactions, including angioedema - Cardiovascular events such as myocardial infarction or stroke

When prescribing meloxicam, clinicians should consider several safety precautions to minimize risks.

Cardiovascular risk assessment: evaluate history of heart disease or stroke before use. Renal function monitoring: check kidney status, especially in patients with dehydration or pre‑existing renal impairment. Gastrointestinal protection: use the lowest effective dose and consider gastro‑protective agents in high‑risk individuals. Hypersensitivity screening: avoid in patients with known allergy to meloxicam or other NSAIDs. Elderly caution: monitor closely for GI bleeding and renal dysfunction in older adults. Store at ambient temperature: keep tablets below 25 °C in the original packaging, protected from moisture.

Meloxicam can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal function when combined. - Lithium: meloxicam can raise lithium serum concentrations. - Methotrexate: potential for increased methotrexate toxicity.